Detalles de la búsqueda
1.
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
JAMA
; 325(16): 1620-1630, 2021 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33734299
2.
Protective effect of Eprosartan against ischemic acute renal injury: Acting on NF-κB, caspase 3, and Sirtuin 1.
Int Immunopharmacol
; 115: 109690, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36640709
3.
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial.
Thromb Haemost
; 123(7): 723-733, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36944357
4.
Hematological Parameters as Diagnostic Factors: Correlation with Severity of COVID-19.
Acta Biomed
; 93(2): e2022061, 2022 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35546008
5.
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial.
Thromb Haemost
; 122(1): 131-141, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33865239
6.
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.
Thromb Res
; 196: 382-394, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32992075
Resultados
1 -
6
de 6
1
Próxima >
>>